Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC)RADIOLOGIA MEDICAIF4.82022-10-086PRE
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study groupCLINICAL & EXPERIMENTAL METASTASISIF3.22021-11-0818PREAI
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-upRADIOLOGIA MEDICAIF4.82020-03-126PREAI
CREO Project: exploratory radiomics for predicting adaptive radiotherapy in NSCLCRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Multimodality treatment in thymic tumors: a retrospective analysis and accordance with ESMOguidelinesRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Correlation between N-L Ratio, P-L Ratio and Survival in patients with LAPC: A new prognostic factor?RADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPCRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
RE-STARTing after lung cancer: impact of a wellbeing event on global health status of survivors.RADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Evaluation of Quality of Life in men with prostate cancer after radiation therapyRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Immune checkpoint inhibitor and encephalic radiotherapy: Toxicity and Adverse eventsRADIOTHERAPY AND ONCOLOGYIF5.32019-04-011OAAI
Impact of target volume delineation on weekly simulation CT during conformal radiotherapy in NSCLCRADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Dosimetric and clinical outcomes of radiotherapy for early-stage lymphoma mediastinal involvement.RADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
The influence of age on survival in elderly patients with resected PC undergoing adjuvant therapy.RADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Patterns of failure according to breast cancer subtype after RT and contemporary systemic therapy.RADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
PET imaging for target volume delineation in rectal cancer radiotherapy: results of a phase II studyRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Radiochemotherapy in borderline re sectable and LAPC: report from three prospective phase II studiesRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Is tumor shrinking during chemoradiation for LA-NSCLC a biomarker for outcome?RADIOTHERAPY AND ONCOLOGYIF5.32018-04-010PREAI
Radiochemotherapy in locally advanced pancreatic cancer: an aged-based analysisRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Age does not affect the benefit of modern chemoradiation for LA-NSCLC patientsRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Outcomes of stereotactic radiotherapy for brain metastases in different breast cancer subtypesRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向